vs

Side-by-side financial comparison of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) and TOP SHIPS INC. (TOPS). Click either name above to swap in a different company.

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is the larger business by last-quarter revenue ($44.6M vs $36.6M, roughly 1.2× TOP SHIPS INC.). TOP SHIPS INC. runs the higher net margin — -12.2% vs -90.4%, a 78.2% gap on every dollar of revenue.

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

Top Ships Inc. is a supply chain maritime transportation operations management company responsible for seaborne trade of raw materials. The company was founded by Evangelos J. Pistiolis on January 10, 2000 and is headquartered in Maroussi, Greece.

PACB vs TOPS — Head-to-Head

Bigger by revenue
PACB
PACB
1.2× larger
PACB
$44.6M
$36.6M
TOPS
Higher net margin
TOPS
TOPS
78.2% more per $
TOPS
-12.2%
-90.4%
PACB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PACB
PACB
TOPS
TOPS
Revenue
$44.6M
$36.6M
Net Profit
$-40.4M
$-4.5M
Gross Margin
37.1%
Operating Margin
-92.3%
22.0%
Net Margin
-90.4%
-12.2%
Revenue YoY
13.8%
Net Profit YoY
-1802.7%
EPS (diluted)
$-0.11
$-0.96

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PACB
PACB
TOPS
TOPS
Q4 25
$44.6M
$36.6M
Q3 25
$38.4M
Q2 25
$39.8M
Q1 25
$37.2M
Q4 24
$39.2M
Q3 24
$40.0M
Q2 24
$36.0M
Q1 24
$38.8M
Net Profit
PACB
PACB
TOPS
TOPS
Q4 25
$-40.4M
$-4.5M
Q3 25
$-38.0M
Q2 25
$-41.9M
Q1 25
$-426.1M
Q4 24
$2.4M
Q3 24
$-60.7M
Q2 24
$-173.3M
Q1 24
$-78.2M
Gross Margin
PACB
PACB
TOPS
TOPS
Q4 25
37.1%
Q3 25
41.4%
Q2 25
36.9%
Q1 25
-3.7%
Q4 24
25.6%
Q3 24
25.0%
Q2 24
16.5%
Q1 24
29.1%
Operating Margin
PACB
PACB
TOPS
TOPS
Q4 25
-92.3%
22.0%
Q3 25
-101.1%
Q2 25
-112.8%
Q1 25
-1154.5%
Q4 24
-390.1%
Q3 24
-160.3%
Q2 24
-488.3%
Q1 24
-209.6%
Net Margin
PACB
PACB
TOPS
TOPS
Q4 25
-90.4%
-12.2%
Q3 25
-98.9%
Q2 25
-105.4%
Q1 25
-1146.8%
Q4 24
6.0%
Q3 24
-151.9%
Q2 24
-481.3%
Q1 24
-201.4%
EPS (diluted)
PACB
PACB
TOPS
TOPS
Q4 25
$-0.11
$-0.96
Q3 25
$-0.13
Q2 25
$-0.14
Q1 25
$-1.44
Q4 24
$-0.44
Q3 24
$-0.22
Q2 24
$-0.64
Q1 24
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PACB
PACB
TOPS
TOPS
Cash + ST InvestmentsLiquidity on hand
$279.5M
$20.4M
Total DebtLower is stronger
$216.6M
Stockholders' EquityBook value
$5.3M
$89.2M
Total Assets
$784.1M
$333.6M
Debt / EquityLower = less leverage
2.43×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PACB
PACB
TOPS
TOPS
Q4 25
$279.5M
$20.4M
Q3 25
$298.7M
Q2 25
$314.7M
Q1 25
$343.1M
Q4 24
$389.9M
Q3 24
$471.1M
Q2 24
$509.8M
Q1 24
$561.9M
Total Debt
PACB
PACB
TOPS
TOPS
Q4 25
$216.6M
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
PACB
PACB
TOPS
TOPS
Q4 25
$5.3M
$89.2M
Q3 25
$36.1M
Q2 25
$61.5M
Q1 25
$91.6M
Q4 24
$506.6M
Q3 24
$453.1M
Q2 24
$492.7M
Q1 24
$649.0M
Total Assets
PACB
PACB
TOPS
TOPS
Q4 25
$784.1M
$333.6M
Q3 25
$803.2M
Q2 25
$825.5M
Q1 25
$860.8M
Q4 24
$1.3B
Q3 24
$1.5B
Q2 24
$1.5B
Q1 24
$1.7B
Debt / Equity
PACB
PACB
TOPS
TOPS
Q4 25
2.43×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PACB
PACB
TOPS
TOPS
Operating Cash FlowLast quarter
$-19.1M
$26.4M
Free Cash FlowOCF − Capex
$-19.9M
FCF MarginFCF / Revenue
-44.6%
Capex IntensityCapex / Revenue
1.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PACB
PACB
TOPS
TOPS
Q4 25
$-19.1M
$26.4M
Q3 25
$-18.7M
Q2 25
$-29.4M
Q1 25
$-44.1M
Q4 24
$-30.6M
Q3 24
$-45.5M
Q2 24
$-54.3M
Q1 24
$-75.7M
Free Cash Flow
PACB
PACB
TOPS
TOPS
Q4 25
$-19.9M
Q3 25
$-18.8M
Q2 25
$-29.9M
Q1 25
$-45.4M
Q4 24
$-32.3M
Q3 24
$-46.3M
Q2 24
$-55.7M
Q1 24
$-79.6M
FCF Margin
PACB
PACB
TOPS
TOPS
Q4 25
-44.6%
Q3 25
-48.9%
Q2 25
-75.3%
Q1 25
-122.3%
Q4 24
-82.3%
Q3 24
-115.7%
Q2 24
-154.8%
Q1 24
-205.0%
Capex Intensity
PACB
PACB
TOPS
TOPS
Q4 25
1.9%
Q3 25
0.2%
Q2 25
1.4%
Q1 25
3.7%
Q4 24
4.1%
Q3 24
2.0%
Q2 24
4.1%
Q1 24
10.0%
Cash Conversion
PACB
PACB
TOPS
TOPS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-12.93×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

TOPS
TOPS

Segment breakdown not available.

Related Comparisons